Compliance and satisfaction with switching from an immediate-release to sustained-release formulation of valproate in people with epilepsy

Author： Doughty J. Baker G.A. Jacoby A. Lavaud V.

Publisher： Elsevier

ISSN： 1525-5050

Source： Epilepsy & Behavior, Vol.4, Iss.6, 2003-12, pp. : 710-716

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Overdose with sustained-release lithium preparations

By Astruc B. Petit P. Abbar M.

European Psychiatry, Vol. 14, Iss. 3, 1999-06 ,pp. : 172-174

Elsevier

Access to resources Recommend Favorite

Can we predict short-term side effects of methylphenidate immediate-release?

By Karabekiroglu Koray Yazgan Yanki Dedeoglu Ceyda

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 1, 2008-01 ,pp. : 48-54

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Sustained-release naltrexone formulations for the treatment of alcohol and opioid dependence

By Volpicelli Joseph R Fenton Miriam

Future Neurology, Vol. 1, Iss. 4, 2006-07 ,pp. : 389-398

Future Medicine

Access to resources Recommend Favorite

Comparison of the bioavailability of unequal doses of divalproex sodium extended-release formulation relative to the delayed-release formulation in healthy volunteers

By Dutta S. Zhang Y. Selness D.S. Lee L.L. Williams L.A. Sommerville K.W.

Epilepsy Research, Vol. 49, Iss. 1, 2002-03 ,pp. : 1-10

Elsevier

Access to resources Recommend Favorite

Once-Daily Venlafaxine Extended Release (XR) and Venlafaxine Immediate Release (IR) in Outpatients with Major Depression

By Cunningham L.A.

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 09, Iss. 3, 1997-09 ,pp. : 157-164

Springer Publishing Company

Access to resources Recommend Favorite